Facioscapulohumeral Muscular Dystrophy (FSHD) Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Magnetic Resonance Imaging and Ultrasound Comparison With Load Evaluation
Conditions: Muscular Dystrophy, Facioscapulohumeral Interventions: Diagnostic Test: Muscle ultrasound with surface electromyography and dynamometry; Diagnostic Test: MRI scan Sponsors: Radboud University Medical Center; Solve FSHD Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 26, 2024 Category: Research Source Type: clinical trials

A Bicentric, Randomized, Double Blind, Placebo-controlled Pilot Study to Evaluate the Efficacy and Safety of Satralizumab in FSHD1
Conditions: Facioscapulohumeral Muscular Dystrophy 1 Interventions: Drug: Satralizumab Prefilled Syringe; Drug: Placebo Comparator Sponsors: Centre Hospitalier Universitaire de Nice Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2024 Category: Research Source Type: clinical trials

Study of ARO-DUX4 in Adult Patients With Facioscapulohumeral Muscular Dystrophy Type 1
Conditions: Facio-Scapulo-Humeral Dystrophy Interventions: Drug: ARO-DUX4 for Injection; Drug: Placebo Sponsors: Arrowhead Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 15, 2023 Category: Research Source Type: clinical trials

Unraveling Metabolic Involvement in Facioscapulohumeral Dystrophy Through Metabolomics
Conditions: Facioscapulohumeral Muscular Dystrophy Interventions: Other: metabolomic on plasma sample Sponsors: University Hospital, Angers; University of Modena and Reggio Emilia; Federico II University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 17, 2023 Category: Research Source Type: clinical trials

An 18-month Prospective Natural History Study to Gain Insight Into FSHD2 Pathophysiology and Disease Progression
Conditions: Facioscapulohumeral Muscular Dystrophy Type 2 Interventions: Diagnostic Test: Validation of new COMs for FSHD2 patients Sponsors: Centre Hospitalier Universitaire de Nice Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 12, 2023 Category: Research Source Type: clinical trials

New Biomarkers in Facioscapulohumeral Muscular Dystrophy, Multispectral Optoacoustic Tomography.
Condition: FSHD Intervention: Device: MSOT Acuity Echo Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 15, 2023 Category: Research Source Type: clinical trials